Close

Pfizer introduces new line of dietary supplements

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Boehringer Ingelheim Integrates Owkin K Pro AI to Accelerate Drug Discovery

Boehringer Ingelheim has joined other pharmaceutical leaders in deploying Owkin's agentic AI scientist, K Pro, to analyze multimodal patient data in oncology and immunology R&D.

EMA Initiates Data Sharing Pilot for New Approach Methodologies

The European Medicines Agency has launched a voluntary framework for sharing data from non-animal testing methods to build regulatory confidence and refine drug development.
- Advertisement -

Pfizer Consumer Healthcare has introduced a new line of dietary supplements ProNutrients, which are formulated to naturally work with a multivitamin.The dietary supplements include Omega-3, Probiotic, and Fruit & Veggie.

Omega-3 provides two Omega-3s (according to Eicosapentaenoic Acid/EPA and Docosahexaenoic Acid/DHA standards) in an ultra-concentrated MiniGel.Omega-3, due to its smaller size, is easy to swallow and support heart health, brain structure and eye structure, claims the company.

New ProNutrients Fruit & Veggie is obtained from grapes, blueberries, raspberries, plums, carrots and tomatoes which support cell protection and general health.

Moreover, the new Probiotic is a blend of powders wrapped in packets and are designed to ensure the bacteria arrive active and ready to work in the digestive tract and support immune health and digestive balance.The company has also introduced Centrum Specialist with specific benefits includes Prenatal, Vision, Energy and Heart.

 

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Latest stories

Related stories

Boehringer Ingelheim Integrates Owkin K Pro AI to Accelerate Drug Discovery

Boehringer Ingelheim has joined other pharmaceutical leaders in deploying Owkin's agentic AI scientist, K Pro, to analyze multimodal patient data in oncology and immunology R&D.

EMA Initiates Data Sharing Pilot for New Approach Methodologies

The European Medicines Agency has launched a voluntary framework for sharing data from non-animal testing methods to build regulatory confidence and refine drug development.

How Prescription Medications Can Impair Driving Ability

Medication safety is not limited to achieving the intended...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »